Skip to main content

The New IPO: Lower Costs, Less Chaos



When it came time for Kindred Biosciences Inc.'s $53 million IPO, CEO Richard Chin decided to use a fast-growing software firm's time-saving product and estimated saving a half a million dollars.

For the latest information and news, visit The Workiva News Room.

For the full article, click below.

Thank you

A Workiva team member will follow up with you shortly.

Thank you for registering

You'll receive a confirmation email shortly.

Thank you

You are now subscribed to receive blog updates.

Back to Top